Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells

Type I interferon (IFN) medications cause various adverse reactions, including vascular diseases. Although an association between chemokines and vascular diseases has also been reported, the relationship between type I IFN and chemokines in vascular endothelial cells (VEC) remains unclear. To provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, M, Fujii, T, Hashimoto, M, Yukawa, N, Yoshifuji, H, Ohmura, K, Nakaizumi, A, Mimori, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Science Inc 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444721/
https://www.ncbi.nlm.nih.gov/pubmed/22943205
http://dx.doi.org/10.1111/j.1365-2249.2012.04638.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444721/
https://www.ncbi.nlm.nih.gov/pubmed/22943205
http://dx.doi.org/10.1111/j.1365-2249.2012.04638.x

Ejemplares similares